Objective: The purpose of this study was to investigate whether sevoflurane enhances moderate dose ethanol preconditioning, and whether this additional cardioprotection is associated with glycogen synthase kinase 3β (GSK3β), Akt, mammalian target of rapamycin (mTOR), 70-KDa ribosomal s6 kinase 1 (p70s6K), and/or mitochondrial permeability transition pore (MPTP) opening.
INTRODUCTION
Epidemiological studies have shown that mortality rates for people who regularly drink ethanol in moderation are lower than in abstainers, primarily due to decreased fatal ischemic heart disease. 1 Further, moderate ethanol consumers have lower rates of myocardial infarction compared with abstainers. 2 These beneficial cardiac effects may be due to pleiotropic effects of ethanol on lipids, 3 platelets, and fibrinolytic activity. 4, 5 In addition, experimental studies have revealed that light to moderate regular ethanol consumption renders hearts more tolerant to ischemia-reperfusion injury (ethanol preconditioning) [6] [7] [8] [9] [10] [11] [12] , similar to ischemic preconditioning 13 in which brief episodes ischemia and reperfusion dramatically limit infarct size following prolonged ischemia A recent study suggests that light to moderate regular ethanol consumption in the year prior to myocardial infarction is associated with reduced mortality following myocardial infarction. 14 These findings suggest that light to moderate ethanol consumption not only prevents myocardial infarction but also improves survival after myocardial infarction.
Over the last 15 years, experimental and clinical studies have indicated that the use of volatile anesthetics constitutes an additional therapeutic approach in the care of patients at risk of developing perioperative cardiac complications, known as volatile anesthetic preconditioning. 15 It has been shown that preconditioned myocardium can also be protected by pharmacological agents such as erythropoietin. 16 volatile anesthetics 17 and ethanol. 18, 19 We previously demonstrated that regular ethanol consumption renders hearts more tolerant to ischemia-reperfusion injury, to a degree similar to acute ischemic preconditioning. 6 We also reported that sevoflurane enhances low dose (2.5%) ethanol-induced preconditioning through modulation of protein kinase C (PKC), mitochondrial K ATP channels (mitoK ATP ) and endothelial nitric oxide synthase (eNOS). 18 However, whether sevoflurane exerts enhanced cardioprotection at higher, clinically relevant, ethanol doses (e.g. 5%) is unknown.
Furthermore, the precise mechanisms which ultimately confer this additive cardioprotection have not been elucidated. Growing evidence suggests that many cardioprotective signaling pathways converge on the mitochondria to reduce cell death. [20] [21] [22] Mitochondrial permeability transition pore (MPTP) opening has been proposed as a crucial determinant of ischemiareperfusion injury. Male guinea pigs weighing 300-350g (3-4 weeks old) were initially given 1.25% ethanol in their drinking water for 1 week, 2.5% for 1 week then 5% for 8 weeks (ethanol group: EtOH). Control group was treated with drinking water for 10 weeks (CTL). After treatment, animals (550-700g, 13-14 weeks old) were given heparin (1000 units intraperitoneally), then anesthetized with pentobarbital (60 mg/kg, intraperitoneally). Hearts were excised and immediately arrested in cold iso-osmotic saline containing 20 mM KCl.
The aorta was cannulated and the isolated hearts were perfused at 70 mmHg on a nonrecirculating isovolumic perfused heart apparatus, using a Krebs-Henseleit perfusate and paced at 240 beats/min as previously described. 32 Serum ethanol levels at time of sacrifice were measured by gas chromatography (Shimadzu, Kyoto, Japan). Liver enzymes were measured to rule out possible liver tissue damage. Sevoflurane was insufflated by passing the 95%O 2 /5%CO 2 gas mixture through a calibrated vaporizer (ACOMA, Tokyo, Japan).
Samples of coronary perfusate were collected anaerobically from the aortic cannula for measurement of sevoflurane concentration by an organic vapor sensor (OSP, Saitama, Japan).
Animals were assigned to one of 8 groups (n=8 each; Figure 1 ). After a 20 min equilibration, baseline left ventricular developed (LVDP; mmHg) and end-diastolic (LVEDP; mmHg) pressures, and coronary flow (CF; mlmin -1 g -1 ) were recorded. Control and EtOH groups were subjected to 30 min of ischemia followed by 120 min of reperfusion.
Anesthetic preconditioning was elicited by administration of sevoflurane (2%) for 10 min followed by 10 min washout before 30 min of ischemia followed by 120 min of reperfusion (SEVO). To investigate whether sevoflurane enhances ethanol preconditioning, ethanoltreated hearts were subjected to the identical protocol of SEVO group (EtOH+SEVO). These doses of LY294002 and rapamycin were previously reported to effectively inhibit PI3K and mTOR, respectively. 34, 35 We performed experiments in the following order (with the laboratory investigator performing the experiments blinded to the groups): first a CTL, followed by ETOH, SEVO, ETOH+SEVO, and so forth until the first series of experiments were completed. The experiments using LY294002 and rapamycin were done in the same manner.
At the end of experiments, the hearts were quickly frozen at -80 °C for 15 min, then sliced into 2 mm thick transverse sections from apex to base (6 slices/heart). Each slice was weighed and incubated at 37 °C with 1% triphenyltetrazolium chloride (Sigma ALDRICHI) in phosphate buffer (pH 7.4) for 10 min and then fixed in 10% formalin for at least 5 h to distinguish red stained viable tissue from pale unstained necrotic tissue. 36 Infarct size was determined using Adobe Photoshop ® CS4 (Adobe, San Jose, USA) as previously described.
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Separate experiments were performed (n=4 in each group) to examine expression of Akt, mTOR, p70s6K and GSK3β. For this purpose, different hearts from infarct size study were used. Myocardial tissue samples were collected at 5 min after reperfusion, and homogenized in ice-cold homogenizing buffer with protein samples and membranes prepared as previously described. 32 After blocking with 5% skim milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T), the membranes were incubated for 2 h at 4 °C in TBS-T containing 5% milk and overnight 1:500-1000 dilution of rabbit primary antibody for phospho Akt (Ser47), mTOR (Ser2448), p70s6K (Thr389) and GSK3β (Ser9) (Cell Signaling TECHNOLOGY, Boston, USA). Membranes were incubated with a 1:1000 dilution of horseradish peroxidase-labeled anti-rabbit immunoglobulin G (NA 934V, GE Healthcare, Buckinghamshire, UK). The same blot was stripped and re-blotted with antibodies to -tubulin (to confirm equal protein loading), total Akt, mTOR, p70s6K and GSK3β (Cell Signaling TECHNOLOGY). Bound antibody signals were detected with enhanced chemiluminescence (Pierce Biotechnology, Rockford, USA) and visualized using VersaDoc 5000 Imaging System (Bio-Rad, Hercules, USA). Quantitative analysis of the band densities was performed by Quantity One software (Bio-Rad) as previously described.
37
To investigate the involvement of MPTP in enhanced cardioprotection, mitochondria were isolated from guinea pig hearts (n=4 for each group). For this purpose, different hearts from infarct size study were used. After perfused and exposed to sevoflurane and inhibitors, isolated hearts were removed from the Langendorff apparatus and homogenized in ice-cold MSTEB buffer as previously described. 37 The extracted mitochondria were diluted in icecold respiratory buffer and incubated with 1μM calcein-AM (Invitrogen Molecular Probes, Carlsbad, USA) for 15 min at room temperature. Calcein-AM readily enters the mitochondria and is trapped in the matrix in its free form, which is fluorescent. After calcein was trapped in mitochondria, the mitochondria were washed by KCl buffer as previously described. 37 Calcein-loaded mitochondria were treated with 50 and 150 μM Ca A group size of n=4 was used for Western blot and calcein studies to provide a power of 0.8 to detect a difference between means of 20% (SD=10, α=0.05). Hemodynamic data were tested for normal distribution and subsequently analyzed by a two-factor repeated-measures analysis of variance for time and treatment. If an overall difference between the variables was observed, comparisons were performed as one-way ANOVA followed by Tukey's post-hoc test for inter-group differences and by Dunnett's for intra-group differences with baseline values as the reference time point. Analysis of infarct size, Western blot and mitochondrial calcein fluorescence was performed using one-way ANOVA followed by Student's t-test with Bonferroni's correction for multiple comparisons to avoid type I error.
For changes within and between groups a two-tailed p value less than 0.05 was considered significant in advance. (SPSS17 for Windows, SPSS Japan, Tokyo, Japan).
RESULTS
Of a total of 170, 10 hearts were not used secondary to intractable ventricular fibrillation after reperfusion (mortality rate was not different among groups) and one heart was not used due to aortic rupture. Additional hearts were studied until each group had n=8 successful experiments. There was no significant difference in body weight among groups.
Serum ethanol level at time of sacrifice was 3.5±2.7 mM. As a comparison, the minimum blood alcohol concentration associated with intoxication in humans is 8 mM (40 mg/dl or 0.04%). Ethanol was not detected in the effluent of the 10 EtOH hearts sampled after 50 min washout. There was no difference in liver enzymes levels between EtOH and CTL animals. expressions. The ratio of phospho mTOR to total mTOR and phospho p70s6K to total p70s6K was not increased in CTL, EtOH and SEVO. However, it was significantly increased in EtOH+SEVO compared with other groups. This increase was abolished by rapamycin (Fig 3) . represented by reduction in calcein fluorescence. This reduction was attenuated in mitochondria from ethanol and sevoflurane exposed hearts, and to an even greater degree in mitochondria from hearts exposed to both moderate ethanol and sevoflurane.
The threshold for MPTP opening is elevated by phosphorylation of GSK3β at Ser 9 , which inactivates this kinase. 26 In turn, GSK3β has been shown to be inactivated by PI3K/Akt and mTOR/p70s6K pathways. 27 In the present study, ethanol or sevoflurane alone increased GSK3β phosphorylation through Akt activation, but not mTOR/p70s6K.
Interestingly, the combination of ethanol and sevoflurane activated both pathways, leading to enhanced phosphorylation of GSK3β. The role of mTOR in cardioprotection remains controversial. Studies have demonstrated a protective effect of rapamycin, an mTOR inhibitor. 41 A recent study demonstrated that cardioprotection by ischemic preconditioning involves both mTOR and Wnt pathways, placing mTOR downstream of GSK3β. 42 In the present study, phosphorylation of both GSK3β and mTOR was seen in only EtOH+SEVO, which was abolished by LY294002. This suggests that PI3K/Akt and GSK3β are important mediators of this additive cardioprotection. Rapamycin failed to abolish the enhanced inhibition of MPTP opening and reduction of infarct size in EtOH+SEVO. However, rapamycin has been shown to protect the heart against ischemia-reperfusion injury through Akt activation. 35, 41 This is consistent with the present study as seen in CTL+Rapa group. The combination of EtOH and sevoflurane may activate additional cardioprotective signaling pathways and mTOR may not be essential for inhibition of MPTP. The exact relationship between GSK3β and mTOR remains unclear, as there is currently no drug available to directly inhibit phosphorylation/inactivation of GSK3β. mTOR consists of two functionally distinct complexes, that is, mTOR complex 1 and complex 2. A component of mTOR complex 2, Rictor (rapamycin-insensitive associated protein of mTOR) has been implicated in activating cell survival. 43 Recently, ethanol has been shown to increase the activity of mTOR complex 2 in myoblast. 44 The potential mechanisms of enhanced cardioprotection by the combination of ethanol and sevoflurane found in this study are summarized in Figure 5 .
The following study limitations should be acknowledged. First, in order to more fully mimic the clinical setting, sevoflurane should be administered throughout experiments.
However, our previous study has shown that a brief exposure to the heart is as effective as continued administration of sevoflurane. 32 Second, we utilized isolated mitochondria exposed to high concentrations of Ca 2+ to evaluate MPTP opening susceptibility in vitro. A previous study demonstrated that the amount of Ca 2+ required to induce MPTP opening depends on the experimental conditions such as the presence of adenine nucleotides in the medium. 45 Although we cannot the possibility that our results may not accurately reflect the conditions experienced by in vivo mitochondria during ischemia-reperfusion, 46 our primary purpose was to assess the susceptibility of MPTP opening in isolated mitochondria exposed to ethanol and sevoflurane. Third, GSK3β is a substrate for multiple pro-survival protein kinases, including Akt, ε-PKC, extracellular signal-regulated kinase 1/2 and protein kinase G 27 . We cannot exclude the possibility that kinases other than PI3K/Akt and mTOR/p70s6K pathways may contribute to enhanced phosphorylation of GSK3β by ethanol and sevoflurane.
Fourth, Krenz et al. demonstrated that acute (as opposed to chronic) ethanol exposure fails to exert cardioprotection when ethanol is present during ischemia-reperfusion. 47 Although not withdrawn from the drinking water before sacrifice in the present study, serum ethanol levels were low (3.5 mM) at the time of sacrifice, and no ethanol was present in the perfusate at the time of ischemia-reperfusion.
In conclusion, sevoflurane enhances cardiac preconditioning induced by moderate, as well as, low dose ethanol consumption. This effect may be mediated by preventing MPTP opening through convergence of protective signaling on GSK3β phosphorylation/inhibition.
Because volatile anesthetics can be administrated with relatively low toxicity, elucidating the mechanisms underlying ethanol and volatile anesthetic-induced preconditioning could hopefully lead to therapies to reduce perioperative myocardial ischemia-reperfusion injury. 
